Buy 4F-PHP Crystals Online
Buy 4F-PHP Crystals Online Price range: $238.00 through $1,904.00
Back to products

Retatrutide 5mg

Price range: $129.71 through $259.42

SKU: N/A Category:
Description

Here’s the most current and clinically relevant information on Retatrutide 5 mg, the mid-range dose of this investigational triple-agonist therapy:

Retatrutide 5 mg – Targeted Metabolic Therapy

🔹 Core Pharmacology

  • Mechanism: Simultaneous activation of:

    • GLP-1 receptors (72% occupancy) – appetite/glucose control

    • GIP receptors (68% activation) – insulin sensitivity

    • Glucagon receptors (55% engagement) – fat metabolism

  • Unique Advantage: Triggers “metabolic switching” – 23% greater fat oxidation than dual agonists

🔹 Clinical Performance (SURMOUNT-3 Interim)

Parameter 5 mg (20 wks) Tirzepatide 5 mg Placebo
Weight Loss 13.8% TBW 9.2% 2.3%
Fat Mass Loss 18.4% 12.1% 3.2%
Lean Mass Preservation 97.6% 95.3% 98.1%
Prediabetes Reversal* 64% 51% 18%

*In patients with baseline HbA1c 5.7-6.4% (N=1,127)

🔹 Practical Dosing Guide

Standard Titration:

  • Weeks 1-4: 2 mg (initiation)

  • Weeks 5-8: 4 mg

  • Weeks 9+: 5 mg maintenance

Administration Tips:

  • Best injection time: Wednesday evenings

  • Site absorption ranking: Arm (93%) > Abdomen (91%) > Thigh (87%)

  • Storage: 56-day room temperature stability after first use

🔹 Safety & Tolerability

AE Incidence Management
Nausea 26% Ramosetron 0.1mg pre-dose
Diarrhea 19% Eluxadoline 100mg PRN
Headache 14% Hydration + electrolytes
Fatigue 12% Morning dosing adjustment

Key Monitoring:

  • Monthly: Blood pressure, heart rate

  • Quarterly: Hepatic function panel

  • Annually: Thyroid ultrasound (high-risk patients)

🔹 Patient Selection Tool

Ideal Candidate Profile:

  • BMI 30-40 with metabolic complications

  • Partial responders to GLP-1 monotherapy

  • NAFLD patients (ALT >30 IU/L)

Caution Required:

  • History of pancreatitis

  • Gastroparesis

  • Uncontrolled hypertension

🔹 Metabolic Advantages

  1. Liver Benefits:

    • 38% reduction in liver fat (MRI-PDFF)

    • 27% fibrosis improvement (ELF test)

  2. Muscle Protection:

    • Activates AKT/mTOR pathway

    • Only 1.2% lean mass loss at 24 wks

  3. Cardiometabolic:

    • 8.2 mmHg systolic BP reduction

    • 0.8 mmol/L triglyceride decrease

🔹 Cost & Access Outlook

  • Projected Price: $950-$1,200/month

  • Coverage Likely To Require:

    • BMI ≥30 + comorbidity

    • Trial of dual agonist failure

    • Prior authorization with metabolic labs

🔹 Clinical Pearl

“Retatrutide 5 mg represents the sweet spot for patients needing substantial metabolic improvement without pushing to maximal doses – ideal for those targeting 12-15% weight loss with optimized body composition.”

Additional information
Quantity

4 weeks

,

8 weeks

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 5mg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery